rethinkPeptides Search
Menu
Study breakdown

Low Body Weight Linked to Reduced Antimicrobial Peptides in People with Latent Tuberculosis

ObservationalModerate evidence
The takeaway

People with latent TB and low BMI had significantly reduced levels of key antimicrobial peptides including LL-37, defensins, and granulysin — potentially explaining why underweight individuals progress to active TB more often.

All 4 AMPs reduced

Every antimicrobial peptide measured was diminished in low BMI latent TB patients compared to normal BMI

What the researchers found

Low BMI individuals with latent TB had diminished systemic, baseline, and mycobacterial antigen-stimulated levels of HNP1-3, granulysin, HBD-2, and cathelicidin compared to normal BMI counterparts, with positive BMI-AMP correlations.

Why it matters

Tuberculosis kills over 1 million people yearly, disproportionately in malnourished populations. Understanding how low BMI impairs antimicrobial peptide defenses could lead to nutritional or peptide-based interventions to prevent TB activation.

The numbers in context

4 AMPs significantly lower in LBMI: HNP1-3, granulysin, HBD-2, cathelicidin; positive correlation with BMI

How the study worked

Observational study comparing systemic and antigen-stimulated antimicrobial peptide levels (HNP1-3, granulysin, HBD-2, LL-37) between LTBI individuals with low BMI versus normal BMI. Measured both circulating levels and immune cell responses to mycobacterial antigens.

Who was studied

Adults with latent tuberculosis infection, comparing low BMI vs normal BMI groups

What this study cannot tell us

Observational — cannot prove causation between low AMP levels and TB progression risk. Sample size not specified. Other immune mechanisms differ between BMI groups. Nutritional interventions not tested.

How to read the evidence

Moderate — well-designed observational comparison with consistent findings across multiple peptides, but lacks longitudinal outcomes and specific sample size reporting.

When this study was published

Published in 2020; the role of antimicrobial peptides in TB susceptibility remains an active research area.

The bigger picture

This study connects nutrition, innate immunity, and TB risk — three areas often studied separately. It suggests that malnutrition-related immunodeficiency operates partly through depleted antimicrobial peptide reserves.

Questions still open

  • Would nutritional supplementation restore antimicrobial peptide levels and reduce TB activation risk?
  • Could exogenous LL-37 or defensin supplementation protect underweight LTBI patients?
  • Are reduced AMP levels a cause of increased TB risk or merely a marker of overall immune suppression?

Common questions

How does low body weight increase TB risk?
Malnutrition weakens the immune system in multiple ways. This study shows one specific mechanism: reduced production of antimicrobial peptides that directly kill TB bacteria and coordinate the immune response against them.
What is cathelicidin/LL-37 and why does it matter for TB?
LL-37 is a human antimicrobial peptide that directly kills mycobacteria and activates immune cells. It is induced by vitamin D, which is why vitamin D deficiency (common in malnourished populations) is linked to TB susceptibility.

Read the original research

Diminished Systemic and Mycobacterial Antigen Specific Anti-microbial Peptide Responses in Low Body Mass Index-Latent Tuberculosis Co-morbidity.

Frontiers in cellular and infection microbiology, 10, 165

Citation

Rajamanickam, Anuradha; Munisankar, Saravanan; Dolla, Chandra Kumar; Babu, Subash. (2020). Diminished Systemic and Mycobacterial Antigen Specific Anti-microbial Peptide Responses in Low Body Mass Index-Latent Tuberculosis Co-morbidity.. Frontiers in cellular and infection microbiology, 10, 165. https://doi.org/10.3389/fcimb.2020.00165